Welcome
Support Centre
03 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The introduction and evaluation of patient-clinician email communication in Merseyside clinical genetics service
ISRCTN ISRCTN18421278
ClinicalTrials.gov identifier
Public title The introduction and evaluation of patient-clinician email communication in Merseyside clinical genetics service
Scientific title
Acronym N/A
Serial number at source N0128162659
Study hypothesis Does email communication have a role in the patient-clinician relationship in clinical genetics? Would patients, who present to the clinical genetics team, use email to communicate with the department?
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Email communication in patient-clinician relationship
Participants - inclusion criteria 1. Referral to clinical genetics
2. Over 16 yrs of age or the parent/guardian of children under 16 yrs of age
3. With access to email
Participants - exclusion criteria Patients attending for prenatal counselling or predictive testing.
Anticipated start date 20/04/2005
Anticipated end date 20/10/2006
Status of trial Completed
Patient information material
Target number of participants 120 participants in total (60 per arm)
Interventions Randomised controlled trial. Intervention group: email address and telephone number. Control group: telephone number only.

Patients will be identified and invited to take part in the study at two separate points in the referral pathway:
1. At the home visit by a genetic counsellor.
2. At the clinic visit by a clinical geneticist and/or Dr Emma McCann.
Primary outcome measure(s) Comparison of "email and telephone" group with "telephone" group only. Is there a difference in the proportions contacting the department? Assess number of contacts per person.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Liverpool Women's Hospital NHS Trust (UK)
NHS R&D Support Funding (UK)
Trial website
Publications
Contact name Dr  Emma  McCann
  Address c/o Royal Liverpool Children's Hospital
Eaton Road
  City/town Liverpool
  Zip/Postcode L12 2AP
  Country United Kingdom
  Tel +44 (0)151 252 5239
  Fax +44 (0)151 252 5951
  Email
Sponsor Record Provided by the NHSTCT Register - 2006 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 29/09/2006
Last edited 09/07/2009
Date ISRCTN assigned 29/09/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central